Hasan Shereen, Hosseini Ghamartaj, Princivalle Marc, Dong Ji-Cui, Birsan Daniela, Cagide Cristina, de Agostini Ariane I
Infertility Clinic, Department of Gynaecology and Obstetrics, Geneva University Hospital, 1211 Geneva 14, Switzerland.
Biol Reprod. 2002 Jan;66(1):144-58. doi: 10.1095/biolreprod66.1.144.
During the reproductive cycle, ovarian follicles undergo major tissue-remodeling involving vascular changes and proteolysis. Anticoagulant heparan sulfate proteoglycans (aHSPGs) are expressed by granulosa cells during the development of the ovarian follicle. The function of aHSPGs in the ovary is unknown, but they might be involved in proteolysis control through binding and activation of serine protease inhibitors. To identify functional interactions between aHSPGs and heparin-binding protease inhibitors in the follicle, we have coordinately localized aHSPGs, antithrombin III, protease nexin-1, and plasminogen activator inhibitor-1 in the rat ovary during natural and gonadotropin-stimulated cycles. Anticoagulant HSPGs were visualized by autoradiography of cryosections incubated with 125I-antithrombin III, and protease inhibitors were assessed by immunohistochemistry and Northern blot hybridization. Anticoagulant HSPGs were expressed in follicles before ovulation, were transiently decreased in postovulatory follicles, and were abundant in the corpus luteum, mainly on capillaries. Anticoagulant HSPGs were colocalized with protease nexin-1 in follicles from the early antral stage until ovulation, with antithrombin III in the preovulatory stage and after ovulation, and with plasminogen activator inhibitor-1 in the corpus luteum. These data demonstrate that aHSPGs are critically expressed in the ovary to interact sequentially with protease nexin-1, antithrombin III, and plasminogen activator inhibitor-1 during the cycle. The specificity of these inhibitors is shifted toward thrombin inhibition in the presence of heparin, suggesting that aHSPGs direct their action to control fibrin deposition in the follicle. The occupation of aHSPGs antithrombin-binding sites by mutant R393C antithrombin III, injected in the ovarian bursa, decreased ovulation efficiency, further supporting the involvement of aHSPGs in the ovulation process.
在生殖周期中,卵巢卵泡经历涉及血管变化和蛋白水解的主要组织重塑过程。抗凝血硫酸乙酰肝素蛋白聚糖(aHSPGs)在卵巢卵泡发育过程中由颗粒细胞表达。aHSPGs在卵巢中的功能尚不清楚,但它们可能通过结合和激活丝氨酸蛋白酶抑制剂参与蛋白水解控制。为了确定卵泡中aHSPGs与肝素结合蛋白酶抑制剂之间的功能相互作用,我们在自然周期和促性腺激素刺激周期中对大鼠卵巢中的aHSPGs、抗凝血酶III、蛋白酶nexin-1和纤溶酶原激活物抑制剂-1进行了协同定位。通过用125I-抗凝血酶III孵育的冷冻切片的放射自显影观察抗凝血HSPGs,通过免疫组织化学和Northern印迹杂交评估蛋白酶抑制剂。抗凝血HSPGs在排卵前的卵泡中表达,在排卵后的卵泡中短暂减少,在黄体中丰富,主要在毛细血管上。抗凝血HSPGs在早期卵泡期直至排卵的卵泡中与蛋白酶nexin-1共定位,在排卵前阶段和排卵后与抗凝血酶III共定位,在黄体中与纤溶酶原激活物抑制剂-1共定位。这些数据表明,aHSPGs在卵巢中关键表达,在周期中与蛋白酶nexin-1、抗凝血酶III和纤溶酶原激活物抑制剂-1依次相互作用。在肝素存在下,这些抑制剂的特异性转向凝血酶抑制,表明aHSPGs直接发挥作用以控制卵泡中的纤维蛋白沉积。向卵巢囊中注射突变型R393C抗凝血酶III占据aHSPGs的抗凝血酶结合位点,降低了排卵效率,进一步支持aHSPGs参与排卵过程。